Main Menu

Supporting Research. Empowering Families.

Research Update: Development of drug for the chemoprevention and/or treatment of HDGC Project Updates Project: Development of drug for the chemoprevention and/or treatment of HDGC Lyvianne Decourtye-Espiard PhD February 2022 We have proposed that the loss of E-cadherin due to pathogenic CDH1 mutations creates vulnerabilities in early-stage T1a gastric cancer cells that can be...

No Stomach For Cancer commits $289,000 to Hereditary Diffuse Gastric Cancer (HDGC) research through 2023. Universidade do Porto Grant Announcement: NICE Project - Nuclear biomarkers for predictive prognosis of hereditary diffuse gastric cancer E-cadherin germline mutations are causative events of Hereditary Diffuse Gastric Cancer (HDGC). Affected individuals are usually diagnosed at advanced stages of...

Research Study: Paving the Way: A Grounded Theory of Discovery and Decision Making for Individuals With the CDH1 Marker PURPOSE: To understand the process of discovery and decision making for adults with the CDH1 marker for hereditary diffuse gastric cancer and inherited breast cancer. PARTICIPANTS & SETTING: Purposeful sampling included 20 participants: 17 adults (11 women and 6 men aged 23–77 years) recruited...

John's March Against Stomach Cancer Raises 23K for No Stomach For Cancer Sonoma, CA - January 24, 2017 - John's March Against Stomach Cancer reached new heights at Sonoma Raceway on Saturday, Jan. 21, as the 6th annual event raised more than $23,000 for the fight against gastric cancer. Nearly 350 people turned out for the No Stomach For Cancer fundraiser, which...
Page 1 of 5